pmc logo image
Logo of annsurgJournal URL: http://www.annalsofsurgery.com
Journal List > Ann Surg > v.227(1); Jan 1998

Formats:
Ann Surg. 1998 January; 227(1): 120–125.
PMCID: PMC1191181
Copyright notice
Incidence of infectious complications associated with the use of histamine2-receptor antagonists in critically ill trauma patients.
G E O'Keefe, L M Gentilello, and R V Maier
Department of Surgery, University of Washington, Harborview Medical Center, Seattle, USA.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
OBJECTIVE: To determine the impact of histamine2 (H2)-receptor antagonist use on the occurrence of infectious complications in severely injured patients. SUMMARY BACKGROUND DATA: Some previous studies suggest an increased risk of nosocomial pneumonia associated with the use of H2-receptor blockade in critically ill patients, but other investigations suggest an immune-enhancing effect of H2-receptor antagonists. The purpose of this study was to determine whether H2-receptor antagonist use affects the overall incidence of infectious complications. METHODS: Patients enrolled in a randomized trial comparing ranitidine with sucralfate for gastritis prophylaxis were examined for all infectious complications during their hospitalization. Data on the occurrence of pneumonia were prospectively collected, and other infectious complications were retrospectively obtained from the medical record. The relative risk of infectious complications associated with ranitidine use and total infectious complications were analyzed. RESULTS: Of 98 patients included, the charts of 96 were available for review. Sucralfate was given to 47, and 49 received ranitidine. Demographic factors were similar between the groups. Ranitidine use was associated with a 1.5-fold increased risk of developing any infectious complication (37 of 47 vs. 26 of 47; 95% confidence interval, 1.04 to 2.28). Infectious complications totaled 128 in the ranitidine-treated group and 50 in the sucralfate-treated group (p = 0.0014). These differences remained after excluding catheter-related infections (p = 0.0042) and secondary bacteremia (p = 0.0046). CONCLUSIONS: Ranitidine use in severely injured patients is associated with a statistically significant increase in overall infectious complications when compared with sucralfate. These results indicate that ranitidine should be avoided where possible in the prophylaxis of stress gastritis.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (926K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 120
120
icon of scanned page 121
121
icon of scanned page 122
122
icon of scanned page 123
123
icon of scanned page 124
124
icon of scanned page 125
125
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994 Feb 10;330(6):377–381. [PubMed]
  • Neugebauer E, Lorenz W, Beckurts T, Maroske D, Merte H. Significance of histamine formation and release in the development of endotoxic shock: proof of current concepts by randomized controlled studies in rats. Rev Infect Dis. 1987 Sep–Oct;9 Suppl 5:S585–S593. [PubMed]
  • Hahm KB, Kim WH, Lee SI, Kang JK, Park IS. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients. Scand J Gastroenterol. 1995 Mar;30(3):265–271. [PubMed]
  • Rixen D, Neugebauer E, Lechleuthner A, Buschauer A, Nagelschmidt M, Thoma S, Rink A. Beneficial effect of H2-agonism and H1-antagonism in rat endotoxic shock. Shock. 1994 Jul;2(1):47–52. [PubMed]
  • Maier RV, Mitchell D, Gentilello L. Optimal therapy for stress gastritis. Ann Surg. 1994 Sep;220(3):353–363. [PubMed]
  • Cheung LY. Thomas G Orr Memorial Lecture. Pathogenesis, prophylaxis, and treatment of stress gastritis. Am J Surg. 1988 Dec;156(6):437–440. [PubMed]
  • Hastings PR, Skillman JJ, Bushnell LS, Silen W. Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med. 1978 May 11;298(19):1041–1045. [PubMed]
  • Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med. 1987 Apr;106(4):562–567. [PubMed]
  • Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996 Jan 24;275(4):308–314. [PubMed]
  • Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 Aug 23;274(8):639–644. [PubMed]
  • Antonelli M, Moro ML, Capelli O, De Blasi RA, D'Errico RR, Conti G, Bufi M, Gasparetto A. Risk factors for early onset pneumonia in trauma patients. Chest. 1994 Jan;105(1):224–228. [PubMed]
  • Rodriguez JL, Gibbons KJ, Bitzer LG, Dechert RE, Steinberg SM, Flint LM. Pneumonia: incidence, risk factors, and outcome in injured patients. J Trauma. 1991 Jul;31(7):907–914. [PubMed]
  • Cook DJ, Laine LA, Guyatt GH, Raffin TA. Nosocomial pneumonia and the role of gastric pH. A meta-analysis. Chest. 1991 Jul;100(1):7–13. [PubMed]
  • Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, Kunches LM, Farber HW, Wedel SA, McCabe WR. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med. 1987 Nov 26;317(22):1376–1382. [PubMed]
  • Mehta J, Powles RL, Treleaven J, Shields M, Agrawal S, Rege K, Mitchell P, Allard S. Cimetidine-induced myelosuppression after bone marrow transplantation. Leuk Lymphoma. 1994 Mar;13(1-2):179–181. [PubMed]
  • Nielsen HJ, Nielsen H, Jensen S, Moesgaard F. Ranitidine improves postoperative monocyte and neutrophil function. Arch Surg. 1994 Mar;129(3):309–315. [PubMed]
Articles from Annals of Surgery are provided here courtesy of
Lippincott, Williams, and Wilkins

PubMed articles by these authors